全文获取类型
收费全文 | 60833篇 |
免费 | 4575篇 |
国内免费 | 210篇 |
专业分类
耳鼻咽喉 | 780篇 |
儿科学 | 1578篇 |
妇产科学 | 1142篇 |
基础医学 | 7984篇 |
口腔科学 | 1577篇 |
临床医学 | 6208篇 |
内科学 | 12536篇 |
皮肤病学 | 910篇 |
神经病学 | 5695篇 |
特种医学 | 2913篇 |
外国民族医学 | 6篇 |
外科学 | 8937篇 |
综合类 | 936篇 |
一般理论 | 47篇 |
预防医学 | 5294篇 |
眼科学 | 1400篇 |
药学 | 3792篇 |
中国医学 | 75篇 |
肿瘤学 | 3808篇 |
出版年
2022年 | 366篇 |
2021年 | 980篇 |
2020年 | 742篇 |
2019年 | 992篇 |
2018年 | 1137篇 |
2017年 | 943篇 |
2016年 | 1057篇 |
2015年 | 1268篇 |
2014年 | 1716篇 |
2013年 | 2424篇 |
2012年 | 3622篇 |
2011年 | 3810篇 |
2010年 | 2140篇 |
2009年 | 1964篇 |
2008年 | 3512篇 |
2007年 | 3661篇 |
2006年 | 3584篇 |
2005年 | 3520篇 |
2004年 | 3313篇 |
2003年 | 3252篇 |
2002年 | 3102篇 |
2001年 | 998篇 |
2000年 | 1030篇 |
1999年 | 981篇 |
1998年 | 747篇 |
1997年 | 589篇 |
1996年 | 548篇 |
1995年 | 516篇 |
1994年 | 423篇 |
1993年 | 384篇 |
1992年 | 665篇 |
1991年 | 628篇 |
1990年 | 570篇 |
1989年 | 595篇 |
1988年 | 510篇 |
1987年 | 525篇 |
1986年 | 531篇 |
1985年 | 523篇 |
1984年 | 487篇 |
1983年 | 433篇 |
1982年 | 439篇 |
1981年 | 383篇 |
1980年 | 347篇 |
1979年 | 408篇 |
1978年 | 349篇 |
1977年 | 310篇 |
1975年 | 295篇 |
1974年 | 328篇 |
1973年 | 284篇 |
1972年 | 291篇 |
排序方式: 共有10000条查询结果,搜索用时 734 毫秒
1.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
2.
3.
4.
5.
6.
Benyam Kinde Harrison W. Gabel Caitlin S. Gilbert Eric C. Griffith Michael E. Greenberg 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(22):6800-6806
DNA methylation at CpG dinucleotides is an important epigenetic regulator common to virtually all mammalian cell types, but recent evidence indicates that during early postnatal development neuronal genomes also accumulate uniquely high levels of two alternative forms of methylation, non-CpG methylation and hydroxymethylation. Here we discuss the distinct landscape of DNA methylation in neurons, how it is established, and how it might affect the binding and function of protein readers of DNA methylation. We review studies of one critical reader of DNA methylation in the brain, the Rett syndrome protein methyl CpG-binding protein 2 (MeCP2), and discuss how differential binding affinity of MeCP2 for non-CpG and hydroxymethylation may affect the function of this methyl-binding protein in the nervous system. 相似文献
7.
8.
9.
The retroviral protease of human immunodeficiency virus (HIV) is an excellent target for antiviral inhibitors for treating HIV/AIDS. Despite the efficacy of therapy, current efforts to control the disease are undermined by the growing threat posed by drug resistance. This review covers the historical background of studies on the structure and function of HIV protease, the subsequent development of antiviral inhibitors, and recent studies on drug-resistant protease variants. We highlight the important contributions of Dr. Stephen Oroszlan to fundamental knowledge about the function of the HIV protease and other retroviral proteases. These studies, along with those of his colleagues, laid the foundations for the design of clinical inhibitors of HIV protease. The drug-resistant protease variants also provide an excellent model for investigating the molecular mechanisms and evolution of resistance. 相似文献
10.
J. Savige L. Amos Frank Ierino H. G. Mack R. C. Andrew Symons P. Hughes 《Ophthalmic genetics》2016,37(4):369-376
Background: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical haemolytic uremic syndrome. It also reviews our understanding of drusen pathogenesis and their relevance for glomerular disease. Methods: Six individuals with dense deposit disease and one with atypical haemolytic uremic syndrome were studied from 2 to 40 years after presentation. Five had renal transplants. All four who had genetic testing had CFH mutations. Individuals underwent ophthalmological review and retinal photography, and in some cases, optical coherence tomography, and further tests of retinal function. Results: All subjects with dense deposit disease had impaired night vision and retinal drusen or whitish-yellow deposits. Retinal atrophy, pigmentation, and hemorrhage were common. In late disease, peripheral vision was restricted, central vision was distorted, and there were scotoma from sub-retinal choroidal neovascular membranes and atypical serous retinopathy. Drusen were present but less prominent in the young person with atypical uremic syndrome due to a heterozygous CFH mutation. Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound heterozygous or heterozygous CFH mutations. They are useful diagnostically but also impair vision. Drusen have an identical composition to glomerular deposits. They are also identical to the drusen of age-related macular degeneration, and may respond to the same treatments. Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, and monitored regularly for vision-threatening complications. 相似文献